Natural phytosterols prove to lower the low-density lipoprotein level and may reduce the risk of heart disease
24/05/2021
Natural phytosterols prove to lower the low-density lipoprotein level and may reduce the risk of heart disease
24/05/2021
High cholesterol level is prevalent in Hong Kong. About half of the population have hypercholesterolemia. It is one of the major risk factor for cardiovascular diseases. Professor Bernard Cheung of HKU Department of Medicine and Dr. Ching-Lung Cheung of HKU Department of Pharmacy and Pharmacology conducted a 3-week clinical trial in 2015.
Successful Phase 1 Study on Novel FcRn Inhibitor Offers New Direction for Treatment of Autoimmune Disease
04/05/2021
Successful Phase 1 Study on Novel FcRn Inhibitor Offers New Direction for Treatment of Autoimmune Disease
04/05/2021
Combined Use of Immunotherapy Drugs Improves Clinical Outcomes for Patients with Advanced Hepatocellular Carcinoma and Received FDA Approval as a Second-line Therapy for HCC
10/11/2020
Combined Use of Immunotherapy Drugs Improves Clinical Outcomes for Patients with Advanced Hepatocellular Carcinoma and Received FDA Approval as a Second-line Therapy for HCC
10/11/2020
[HKU-CTC Public Education Series] Chapter 2: Four Stages of Clinical Trials
14/09/2020
A new chapter of HKU-CTC Public Education Series named “Four Stages of Clinical Trials” was posted on HKU-CTC Facebook page on September 2, 2020.
[HKU-CTC Public Education Series] Chapter 1: The Journey of Drug Development
15/06/2020
HKU-CTC is launching a Public Education Series explaining the process and particular of clinical trials by simple language and illustrations. The first chapter named “The Journey of Drug Development” was posted on HKU-CTC Facebook page on June 1, 2020.
Immunotherapy Drug Proven Safe and Effective New Treatment for Asian HCC Patients
03/06/2020
Immunotherapy Drug Proven Safe and Effective New Treatment for Asian HCC Patients
03/06/2020
Potential New Treatment for Advanced HCC Went Through Successful Phase 1 and Phase 2 Studies
31/07/2019
Potential New Treatment for Advanced HCC Went Through Successful Phase 1 and Phase 2 Studies
31/07/2019
Successful Study on New Drug for Chronic Lymphocytic Leukemia (CLL) Paves Way for Phase 2 Study on Efficacy and Safety of the Selected Dosage
24/07/2019
Successful Study on New Drug for Chronic Lymphocytic Leukemia (CLL) Paves Way for Phase 2 Study on Efficacy and Safety of the Selected Dosage
24/07/2019
Study Shows New Drugs for Hepatitis C Well-Tolerated in Chinese Participants
24/07/2019
Phase 1 Study Shows Effective Antiviral Response of Novel Drug for Hepatitis B Virus (HBV)
24/07/2019
Phase 1 Study Shows Effective Antiviral Response of Novel Drug for Hepatitis B Virus (HBV)
24/07/2019